# Single-cell RNA sequencing unraveled immune-related expression heterogeneity and lymphoid cell development dysregulation in childhood asthma

**Authors:** Danying Zhu, Guang Li, Lang Yuan, Zeyu Zeng, Na Dong, Chao Wang, Ming Chen, Lijian Xie, Guohui Ding, Libing Shen, Xiaoyan Dong

PMC · DOI: 10.3389/fimmu.2025.1606650 · Frontiers in Immunology · 2026-01-02

## TL;DR

This study uses single-cell RNA sequencing to show that childhood asthma involves immune system imbalances and abnormal lymphoid cell development.

## Contribution

The study reveals dysregulated lymphoid lineage development as a common feature in childhood asthma using single-cell RNA sequencing.

## Key findings

- Both innate and adaptive immunity are imbalanced in childhood asthma patients.
- Dysregulated lymphoid lineage development is observed in all three asthma patients.
- S100A8, S100A9, S100A12, and RETN are universally upregulated in asthma patients' cell types.

## Abstract

Asthma is a chronic inflammatory disease affecting airways, usually starting in childhood. Its cause remains unclear.

We aim to elucidate the role of immune dysregulation in the pathogenesis of pediatric asthma.

In this study, we used single-cell RNA sequencing to analyze peripheral blood mononuclear cells (PBMCs) from three pediatric asthma patients and four age-matched healthy controls to investigate the cellular etiology of childhood asthma.

The overall expression patterns of PBMCs from the three asthma patients indicate that both innate and adaptive immunity are imbalanced and abnormally activated in childhood asthma. Analysis of hematopoietic stem and progenitor cells (HSPCs) expression profiles further reveals that HSPCs from asthma patients tend to express immunity-related genes earlier. The cell developmental trajectories observed in asthma patients show an abnormal immune cell development pattern. Dysregulated lymphoid lineage development is observed in all three patients but there is no identical abnormal pattern for each patient. Pseudo-time analysis of gene expression demonstrates that JUN, a gene controlling cell cycle progression, is repressed in asthma patients while SPI1, an essential gene for lymphoid lineage development along with six inflammatory response related genes (S100A8, S100A9, S100A12, IL7R, IL32, and CCL5), exhibit various aberrant expression trajectories in asthmatic individuals. S100A8, S100A9, S100A12, and RETN are universally upregulated in various cell types of asthma patients. The analyses of cell-cell communication further elucidate the contributory roles of dendritic cells and CD14+ monocytes in the development and heterogeneity of asthma, as they exhibit increased reception and transmission of annexin and resistin signals in the asthma group. The resistin protein-protein interaction network analysis further suggests that SQSTM1, HSPA5 and A2M might serve as the potential therapeutic targets in childhood asthma.

Our scRNA-Seq analyses unveil childhood asthma as a complex disease with immune-related heterogenicities, characterized by dysregulated lymphoid cell development, a common feature that may offer a novel research direction for comprehensively understanding the key molecular mechanisms underlying childhood asthma.

## Linked entities

- **Genes:** JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725], SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688], S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279], S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280], S100A12 (S100 calcium binding protein A12) [NCBI Gene 6283], IL7R (interleukin 7 receptor) [NCBI Gene 3575], IL32 (interleukin 32) [NCBI Gene 9235], CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352], RETN (resistin) [NCBI Gene 56729], SQSTM1 (sequestosome 1) [NCBI Gene 8878], HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309], A2M (alpha-2-macroglobulin) [NCBI Gene 2]
- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** IL32 (interleukin 32) [NCBI Gene 9235] {aka IL-32alpha, IL-32beta, IL-32delta, IL-32gamma, NK4, TAIF}, CD14 (CD14 molecule) [NCBI Gene 929], S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279] {aka 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag}, S100A12 (S100 calcium binding protein A12) [NCBI Gene 6283] {aka CAAF1, CAGC, CGRP, ENRAGE, MRP-6, MRP6}, SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688] {aka AGM10, OF, PU.1, SFPI1, SPI-1, SPI-A}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, A2M (alpha-2-macroglobulin) [NCBI Gene 2] {aka A2MD, CPAMD5, FWP007, S863-7}, HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309] {aka BIP, GRP78, HEL-S-89n}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}, RETN (resistin) [NCBI Gene 56729] {aka ADSF, FIZZ3, RENT, RETN1, RSTN, XCP1}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}
- **Diseases:** Asthma (MESH:D001249), immune dysregulation (OMIM:614878), inflammatory (MESH:D007249), asthmatic (MESH:D013224)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12807962/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12807962/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12807962/full.md

---
Source: https://tomesphere.com/paper/PMC12807962